EPIDEMIOLOGICAL TRENDS AND STRUCTURE OF COVID-19 PATIENTS IN THE REPUBLIC OF KHAKASIA IN 2020
Abstract
Background. In March 2020, the number of COVID-19 cases in the world increased 13 times, and the number of countries affected by the virus tripled. During the year, all countries of the world were affected by the COVID-19 pandemic, but the epidemic process has population characteristics.
Purpose. To estimate the morbidity and mortality rates of patients with COVID-19 in the Republic of Khakassia, the structure of patients by sex and age infected with SARS-CoV-2 for 2020
Materials and methods. The incidence and mortality rates of the general population of patients with COVID-19 for 2020 in the republic has been analysed. For statistical processing of the results obtained, the Statistica 8.0 software package was used.
Results. The number of registered cases of COVID-19 in 2020 in the Republic of Khakassia was 17552. There are two conditional growth intervals in the number of infected people in March-August (first wave) and in September-December (second wave). During the 1st wave, the incidence rate increased from 0.2 to 180.4 per 100 thousand of the population. In December, the incidence exceeded the same indicator in Russia by 1.8 times (2646.1 per 100 thousand population). There were three peak values of the mortality rate: in April – 3.1%, in July – 1.8%, in December – 2.4%. The proportion of deaths increases with age. The highest mortality rate is recorded at the age of 50 years and older: the proportion of deaths in this group is 3.7 times higher than at the age of 50-59, 10.6 times more than in the group of 40-49 years and 74 times more than in the young age group (<40 years old). Among the patients of Khakassia, the ratio between men and women was 0.99: 1.0.
Conclusion. The study of the clinical and epidemiological features of the disease continues and is a priority in the development of world health.
Downloads
References
Bazdyrev E.D. Koronavirusnaya infekciya - aktual’naya problema XXI veka [Coronavirus infection is an urgent problem of the XXI century]. Kompleksnye problemy serdechno-sosudistyh zabolevanij [Complex problems of cardiovascular diseases], 2020, no. 2, pp. 6-16. https://doi.org/10.17802/2306-1278-2020-9-2-6-16
Baklaushev V.P., Kulemzin S.V., Gorchakov A.A., Lesnyak V.N., Yusubalieva G.M., Sotnikova A.G. COVID-19. Etiologiya, patogenez, diagnostika i lechenie [Etiology, pathogenesis, diagnosis and treatment]. Klinicheskaya praktika [Clinical practice], 2020, Vol. 11, no. 1, pp. 7-20. https://doi.org/10.17816/clinpract26339
Belocerkovskaya YU.G. Romanovskih A.G., Smirnov I.P. COVID-19: respiratornaya infekciya, vyzvannaya novym koronavirusom: novye dannye ob epidemiologii, klinicheskom techenii, vedenii pacientov [COVID-19: Respiratory Infection Caused by Novel Coronavirus: New Evidence on Epidemiology, Clinical Course, Patient Management]. Consilium Medicum [Consilium Medicum], 2020, vol. 22, no. 3, pp. 12-20. https://doi.org/10.26442/20751753.2020.3.200092
Vremennye metodicheskie rekomendacii. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19) [Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)], Ver. 10 (08.02.2021). M.: Minzdrav RF, 2021, 261 p. https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/%D0%92%D1%80%D0%B5%D0%BC%D0%B5%D0%BD%D0%BD%D1%8B%D0%B5_%D0%9C%D0%A0_COVID-19_%28v.10%29-08.02.2021_%281%29.pdf
Gorenkov D.V., Hantimirova L.M., SHevcov V.A., Rukavishnikov A.V., Merkulov V.A., Olefir YU.V. Vspyshka novogo infekcionnogo zabolevaniya COVID-19: β-koronavirusy kak ugroza global’nomu zdravoohraneniyu [Outbreak of new infectious disease COVID-19: β-coronaviruses as a threat to global health]. BIOpreparaty. Profilaktika, diagnostika, lechenie [BIOPreparations. Prevention, diagnosis, treatment], 2020, vol. 20, no. 1, pp.6-20. https://doi.org/10.30895/2221-996X-2020-20-1-6-20
Malinnikova E. Yu. Novaya koronavirusnaya infekciya. Segodnyashnij vzglyad na pandemiyu XXI veka [New coronavirus infection. Today’s look at the 21st century pandemic], Infekcionnye bolezni: Novosti. Mneniya. Obuchenie [Infectious Diseases: News. Opinions. Education], 2020, no. 2 (33), pp. 18-32. https://www.lsgeotar.ru/ispolzovaniye-ekulizumaba-peresadke-pochek-detey.html
Стопкоронавирус.рф - Official Internet resource for informing the population about the coronavirus (COVID-19). Moscow, 2021. https://стопкоронавирус.рф
Shamsheva O. V. Novyj koronavirus COVID-19 (SARS-COV-2) [Novel coronavirus COVID-19 (SARS-COV-2)], Detskie infekcii [Childhood infections], 2020, no.1, pp. 5-6. https://doi.org/10.22627/2072-8107-2020-19-1-5-6
Ministerio de Salud. Cifras Oficiales COVID-19 Santiago: Ministry of Health, Plan de Acción Coronavirus COVID-19. 2020. https://www.gob.cl/coronavirus/cifrasoficiales/
O’Driscoll M., Dos Santos G.R., Wang L., Cummings D.A.T., Azman A.S., Paireau J., Fontanet A., Cauchemez S., Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature, 2021, vol. 590, pp. 140-147. https://doi.org/10.1038/s41586-020-2918-0
Omori R., Matsuyama R., Nakata Y. The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age. Scientific Reports, 2020, vol. 10, pp. 16642. https://doi.org/10.1038/s41598-020-73777-8
Peckham H., de Gruijter N.M., Raine Ch., Radziszewska A., Ciurtin C., Wedderburn L.R., Rosser E.C., Webb K., Deakin C.T. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications, 2020, vol. 11, pp. 1-10.
Soneji S., Beltrán-Sánchez H., Yang J.W., MannSoneji C. et al. Population-level mortality burden from novel coronavirus (COVID-19) in Europe and North America. Genus, 2021, vol. 77, pp. 7. https://doi.org/10.1186/s41118-021-00115-9
Takahashi Т., Iwasaki А. Sex differences in immune responses. Science, 2021, vol. 371 (6527), pp. 347-348. https://doi.org/10.1126/science.abe7199
Undurraga E.A., Chowell G., Mizumoto K., Undurraga et al. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, 2020. Infect. Dis. Poverty, 2021, vol. 10, pp. 1-11. https://doi.org/10.1186/s40249-020-00785-1
World Health Organization. Coronavirus Disease (COVID-19) Outbreak Geneva: WHO. 2020. https://www.who.int/emergencies/diseases/novel -coronavirus-2019
Wu, J. T. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan. China. Nat. Med., 2020, vol. 26, pp. 506–510. https://doi.org/10.1038/s41591-020-0822-7
Zhu N., Zhang D., Wang W., Li X., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med., 2020, vol. 382, pp. 727-733. https://doi.org/10.1056/NEJMoa2001017
Copyright (c) 2021 Olga V. Shtygasheva, Elizaveta S. Ageeva, Kseniya V. Pronykina, Zinaida Yu. Puzakova
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
